1. Prognostic Model to Predict Overall Survival for Metastatic Non-Small Cell Lung Cancer Patients Treated With Chemotherapy Combined With Concurrent Radiation Therapy to the Primary Tumor: Analysis From Two Prospective Studies
   Ling-Feng Liu et al, 2021, Frontiers in Oncology CrossRef
2. Radiotherapy for Oligometastatic Lung Cancer
   Derek P. Bergsma et al, 2017, Frontiers in Oncology CrossRef
3. Oligorecurrence Non–small Cell Lung Cancer After Failure of First-Line Chemotherapy: Computed Tomography–Guided 125I Seed Implantation vs. Second-Line Chemotherapy
   Hao Wang et al, 2020, Frontiers in Oncology CrossRef
4. Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions
   Felipe Couñago et al, 2019, World Journal of Clinical Oncology CrossRef
5. The Role of Local Treatment in Oligometastatic and Oligoprogressive Cancer
   Jan Haussmann et al, 2019, Deutsches Ärzteblatt international CrossRef
6. Local therapy treatment conditions for oligometastatic non-small cell lung cancer
   Suli Zhang et al, 2022, Frontiers in Oncology CrossRef
7. Current treatment landscape for oligometastatic non-small cell lung cancer
   Javier Garde-Noguera et al, 2022, World Journal of Clinical Oncology CrossRef
8. An Initial Report of a Radiation Dose-Escalation Trial in Patients with One to Five Sites of Metastatic Disease
   Joseph K. Salama et al, 2008, Clinical Cancer Research CrossRef
9. The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
   Max Dahele et al, 2011, Cancer Research and Treatment CrossRef